These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 6190231

  • 1. [Antiperinuclear and antikeratin antibodies in liver diseases].
    Youinou P, Miossec P, Pennec Y, Boles JM, Le Goff P, Le Menn G.
    Sem Hop; 1983 Mar 03; 59(9):589-92. PubMed ID: 6190231
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process.
    Aho K, von Essen R, Kurki P, Palosuo T, Heliövaara M.
    J Rheumatol; 1993 Aug 03; 20(8):1278-81. PubMed ID: 7693940
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic value of antikeratin antibodies in rheumatoid arthritis.
    Ordeig J, Guardia J.
    J Rheumatol; 1984 Oct 03; 11(5):602-4. PubMed ID: 6210364
    [Abstract] [Full Text] [Related]

  • 7. [Antiperinuclear factors in psoriasis. Correlation with other serological abnormalities in 90 patients].
    Youinou P, Massé R, Peu-Duvallon P, Le Roux P, Grulier A, Miossec P, Dorval JC, Lizan G, Férec C, Le Goff P.
    Ann Dermatol Venereol; 1982 Oct 03; 109(4):359-64. PubMed ID: 6751193
    [Abstract] [Full Text] [Related]

  • 8. Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis.
    Westgeest AA, Boerbooms AM, Jongmans M, Vandenbroucke JP, Vierwinden G, van de Putte LB.
    J Rheumatol; 1987 Oct 03; 14(5):893-7. PubMed ID: 3501470
    [Abstract] [Full Text] [Related]

  • 9. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis.
    Janssens X, Veys EM, Verbruggen G, Declercq L.
    J Rheumatol; 1988 Sep 03; 15(9):1346-50. PubMed ID: 3058971
    [Abstract] [Full Text] [Related]

  • 10. The antiperinuclear factor and antikeratin antibody systems.
    Youinou P, Serre G.
    Int Arch Allergy Immunol; 1995 Aug 03; 107(4):508-18. PubMed ID: 7542514
    [Abstract] [Full Text] [Related]

  • 11. Failure to demonstrate any interaction between polyclonal rheumatoid factors and IgG antinuclear antibodies or other IgG autoantibodies.
    Scott-Morgan L, Lloyd RS.
    Clin Exp Immunol; 1980 Aug 03; 41(2):297-302. PubMed ID: 6160005
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
    Zeng X, Ai M, Tian X, Gan X, Shi Y, Song Q, Tang F.
    J Rheumatol; 2003 Jul 03; 30(7):1451-5. PubMed ID: 12858440
    [Abstract] [Full Text] [Related]

  • 13. How useful are tests for rheumatoid factors, antiperinuclear factors, antikeratin antibody, and the HLA DR4 antigen for the diagnosis of rheumatoid arthritis?
    Saraux A, Valls I, Voisin V, Koreichi A, Baron D, Youinou P, Le Goff P.
    Rev Rhum Engl Ed; 1995 Jan 03; 62(1):16-20. PubMed ID: 7540486
    [Abstract] [Full Text] [Related]

  • 14. Lack of relationship between the Epstein-Barr virus and the antiperinuclear factor/'perinuclear antigen' system in rheumatoid arthritis.
    Buisson M, Berthelot JM, Le Goff P, Chastel C, Lamour A, Seigneurin JM, Youinou P.
    J Autoimmun; 1994 Aug 03; 7(4):485-95. PubMed ID: 7980850
    [Abstract] [Full Text] [Related]

  • 15. Anti-intermediate filament antibodies, antikeratin antibody, and antiperinuclear factor in rheumatoid arthritis and infectious mononucleosis.
    Kataaha PK, Mortazavi-Milani SM, Russell G, Holborow EJ.
    Ann Rheum Dis; 1985 Jul 03; 44(7):446-9. PubMed ID: 2411230
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH.
    Hepatogastroenterology; 1997 Jul 03; 44(14):417-25. PubMed ID: 9164512
    [Abstract] [Full Text] [Related]

  • 17. Anti-perinuclear and rheumatoid factor in different forms of autoimmune thyroid disease.
    Scherbaum WA, Youinou PY, Le Goff P, Bottazzo GF.
    Clin Exp Immunol; 1984 Mar 03; 55(3):516-8. PubMed ID: 6608424
    [Abstract] [Full Text] [Related]

  • 18. Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis.
    Saraux A, Berthelot JM, Devauchelle V, Bendaoud B, Chalès G, Le Henaff C, Thorel JB, Hoang S, Jousse S, Baron D, Le Goff P, Youinou P.
    J Rheumatol; 2003 Dec 03; 30(12):2535-9. PubMed ID: 14719190
    [Abstract] [Full Text] [Related]

  • 19. Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection.
    Kessel A, Rosner I, Zuckerman E, Golan TD, Toubi E.
    J Rheumatol; 2000 Mar 03; 27(3):610-2. PubMed ID: 10743797
    [Abstract] [Full Text] [Related]

  • 20. Antibody to stratum corneum (antikeratin antibody) and antiperinuclear factor: markers for progressive rheumatoid arthritis.
    Kurki P, von Essen R, Kaarela K, Isomäki H, Palosuo T, Aho K.
    Scand J Rheumatol; 1997 Mar 03; 26(5):346-9. PubMed ID: 9385344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.